Post Resch Tallon Group Inc. Abbott Laboratories Transaction History
Post Resch Tallon Group Inc.
- $98 Billion
- Q1 2025
A detailed history of Post Resch Tallon Group Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 1,767 shares of ABT stock, worth $236,671. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,767
Previous 1,767
-0.0%
Holding current value
$236,671
Previous $200 Million
15.65%
% of portfolio
0.24%
Previous 0.19%
Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,543Shares Held
1.38BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$22.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.95 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.8 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...